Digital Biomarkers Market: Introduction
- Biomarkers can be defined as objective measures that capture physiological, anatomic, and pathological characteristics of an individual to understand the state of the person and the warning signals being given by the body. Digital biomarkers can be defined as quantifiable behavioral and physiological data that can be collected and measured by employing digital devices such as wearables, digestibles, implantables, and portables.
Read Report Overview – https://www.transparencymarketresearch.com/digital-biomarkers-market.html
- Digital biomarkers aid in offering significant imaging capabilities along with enhanced spatial resolution. Administrations offered in digital biomarkers include stomach aortic aneurysm, aortic analyzation, complex fringe vein ailment, and carotid conduit sickness.
Key Drivers and Restraints of Global Digital Biomarkers Market
- Expansion of the digital biomarkers market can be attributed to an increase in usage of connected digital devices and health-related mobile applications. These devices aid in a range of diagnostic and prognostic measurements over diverse disease areas including mental health, diabetes, neurological diseases, and cardiovascular diseases.
- Rising usage of smartphones and the emergence of smartwatches, which aid in tracking the physiological details of the person’s health, boost the digital biomarkers market. Technological advances in the ranges of mobiles and digitally connected technologies further propel the digital biomarkers market.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79554
- Significant product launches and approvals from the FDA also drive the digital biomarkers market. For instance, in April 2019, the U.S. FDA approved KardiaMobile, by AliveCor, an AI-enabled wearable device that is designed to monitor the person’s vital signs. It helps detect three highly common forms of heart arrhythmias.
- FDA has modified its guidelines related to software-as-medical-device to simplify the entry process for companies operating in the digital biomarkers market. This regulatory flexibility toward digital health solutions is estimated to propel the market during the forecast period.
- However, the clinical assessment of data platforms and other digital biomarkers is important, which is likely to restrain the global digital biomarkers market
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79554
North America to Lead Global Digital Biomarkers Market
- In terms of region, the global digital biomarkers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global digital biomarkers market in 2019, owing to strong presence of leading market players, increase in investments on research & development, significant product launches, and growing approval of smart devices in the region
- Europe followed North America in terms of share of the global digital biomarkers market in 2019. The market in Asia Pacific is projected to expand at a rapid pace, followed by Latin America and Middle East & Africa. Rise in focus of governments of countries in Asia on enhancing healthcare facilities, increase in focus of market players on Asia Pacific to leverage growth opportunities, surge in usage of smart devices, and an increase in the patient pool boost the digital biomarkers market in Asia Pacific.
Pre Book Digital Biomarkers Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=79554<ype=S
Key Players Operating in Global Digital Biomarkers Market
Major market players are focused on expanding their presence in the digital biomarkers market primarily by adopting inorganic growth strategies. Leading players in the global digital biomarkers market are:
- ActiGraph LLC
- Akili Interactive Labs
- AliveCor, Inc.
- Fitbit, Inc.
- HumanAPI
- Novartis
- Pfizer Inc.
- Hoffmann-La Roche Ltd
- Sanofi
- Takeda Pharmaceuticals
- Verily Life Science LLC
More Trending Reports by Transparency Market Research –
Clinical Chemistry Analyzers Market: http://www.prnewswire.com/news-releases/global-clinical-chemistry-analyzers-market-to-reach-a-value-of-us-16-3-bn-by-2027–expanding-at-a-cagr-of-4-over-2019-and-2027-transparency-market-research-301022185.html
Bioreactors and Fermenters Market: https://www.biospace.com/article/bioreactors-and-fermenters-market-single-use-bioreactors-to-witness-increased-adoption/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
